help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Proby, C. M.
Right arrow Articles by Leigh, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Proby, C. M.
Right arrow Articles by Leigh, I. M.

American Journal of Pathology, Vol 143, 1667-1678, Copyright © 1993 by American Society for Investigative Pathology

REGULAR ARTICLES

Keratin 17 expression as a marker for epithelial transformation in viral warts

CM Proby, L Churchill, PE Purkis, MT Glover, CJ Sexton and IM Leigh
Department of Experimental Dermatology, London Hospital Medical College, United Kingdom.

The profile of keratin expression in benign warts from various cutaneous and mucosal sites along with dysplastic warts and squamous cell carcinomas has been examined using a panel of monospecific antibodies to epithelial keratins. Viral warts and verrucous keratoses from immunosuppressed renal transplant recipients show a spectrum of squamous atypia from benign lesions, from minimal changes to full thickness dysplasia. Changes associated with malignancy include loss of differentiation-specific keratins 1 and 10 together with expansion of basal cell epitopes and inappropriate expression of simple epithelial keratins 8, 18, and 19 in advanced squamous cell carcinoma. This late expression of keratins 8 and 18 contrasts with early expression of keratin 17 in all dysplastic lesions examined. Keratin 17 is found suprabasally in hyperproliferative lesions, including benign warts, but marked basal plus suprabasal expression is seen increasingly in malignantly transformed epidermis. These findings were not specific to immunosuppression, as shown by identical findings in control squamous cell carcinoma from nonimmunosuppressed individuals. Keratin 17 expression may prove prognostically helpful when assessing dysplasia in epidermal tumors.


This article has been cited by other articles:


Home page
 Genes Dev.Home page
K. M. McGowan, X. Tong, E. Colucci-Guyon, F. Langa, C. Babinet, and P. A. Coulombe
Keratin 17 null mice exhibit age- and strain-dependent alopecia
Genes & Dev., June 1, 2002; 16(11): 1412 - 1422.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
K. M. McGowan and P. A. Coulombe
Onset of Keratin 17 Expression Coincides with the Definition of Major Epithelial Lineages during Skin Development
J. Cell Biol., October 19, 1998; 143(2): 469 - 486.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Society for Investigative Pathology.